SEARCH

SEARCH BY CITATION

References

  • ALMEIDA, A.P., BAYER, B.M., HORAKOVA, Z. & BEAVEN, M.A. (1980). Influence of indomethacin and other anti-inflammatory drugs on mobilization and production of neutrophils: studies with carrageenan-id inflammation in rats. J. Pharmacol. Exp. Ther., 214, 7479.
  • ANDERSON, G.D., HAUSER, S.D., MCGARITY, K.L., BREMER, M.E., ISAKSON, P.C. & GREGORY, S.A. (1996). Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest., 97, 26722679.
  • ARIAS-NEGRETE, S., KELLER, K. & CHADEE, K. (1995). Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem. Biophys. Res. Commun., 208, 582589.
  • BJARNASON, I., MACPHERSON, A., ROTMAN, H., SCHUPP, J. & HAYLLAR, J. (1997). A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen. Scand. J. Gastroenterol., 32, 126130.
  • BRIDEAU, C., VAN STADEN, C., STYHLER, A., RODGER, I.W. & CHAN, C.C. (1999). The effects of phosphodiesterase type 4 inhibitors on tumor necrosis factor-a and leukotriene B4 in a novel human whole blood assay. Brit. J. Pharmacol., 126, 979988.
  • CHAN, C.C., BOYCE, S., BRIDEAU, C., FORD-HUTCHINSON, A.W., GORDON, R., GUAY, D., HILL, R.G., LI, C.S., MANCINI, J., PENNETON, M., PRASIT, P., RASORI, R., RIENDEAU, D., ROY, P., TAGARI, P., VICKERS, P., WONG, E. & RODGER, I.W. (1995). Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and non human primate stomach. J. Pharmacol. Exp. Ther., 274, 15311537.
  • FUNK, C.D., FUNK, L.B., KENNEDY, M.E., PONG, A.S. & FITZGERALD, G.A. (1991). Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J., 5, 23042312.
  • FURST, D.E. (1997). Meloxicam: selective COX-2 inhibition in clinical practice. Semin. Arthritis Rheum., 26, 2127.
  • HEMPLE, S.L., MONICK, M.M. & HUNNINGHAKE, G.W. (1994). Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J. Clin. Invest., 93, 391396.
  • HERSCHMAN, H.R. (1996). Prostaglandin synthase 2. Biochim. Biophys. Acta., 1299, 125140.
  • HIGGS, G.A., EAKINS, K.E., MUGRIDGE, K.G., MONCADA, S. & VANE, J.R. (1980). The effects of non-steroid anti-inflammatory drugs on leukocyte migration in carrageenan-induced inflammation. Eur. J. Pharmacol., 66, 8186.
  • JONES, D.A., CARLTON, D.P., MCINTYRE, T.M., ZIMMERMAN, G.A. & PRESCOTT, S.M. (1993). Molecular cloning of human prostaglandin H synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem., 268, 90499054.
  • KARGMAN, S., CHARLESON, S., CARTWRIGHT, M., FRANK, J., RIENDEAU, D., MANCINI, J., EVANS, J. & O'NEILL, G. (1996). Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology, 111, 445454.
  • KARGMAN, S.L., O'NEILL, G.P., VICKERS, P.J., EVANS, J.F., MANCINI, J.A. & JOTHY, S. (1995). Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55, 25562559.
  • KENNEDY, B.P., CHAN, C.C., CULP, S.A. & CROMLISH, W.A. (1993). Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA. Biochem. Biophys. Res. Commun., 197, 494500.
  • KHANNA, I.K., WEIER, R.M., YU, Y., COLLINS, P.W., MIYASHIRO, J.M., KOBOLDT, C.M., VEENHUIZEN, A.W., CURRIE, J.L., SEIBERT, K. & ISAKSON, P.C. (1997). 1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2. J. Med. Chem., 40, 16191633.
  • LANE, N.E. (1997). Pain management in osteoarthritis: the role of COX-2 inhibitors. J. Rheumatol., 24, 2024.
  • LEE, S.H., SOYOOLA, E., CHANMUNGAM, P., HART, S., SUN, W., ZHONG, H., LIOU, S., SIMMONS, D. & HWANG, D. (1992). Selective expression of mitogen-inducible cyclooxygenase in macrophage stimulated with lipopolysaccharide. J. Biol. Chem., 267, 2593425938.
  • MNICH, S.J., VEENHUIZEN, A.W., MONAHAN, J.B., SHEEHAN, K.C., LYNCH, K.R., ISAKSON, P.C. & PORTANOVA, J.P. (1995). Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2. J. Immunol., 155, 44374444.
  • MURAKAMI, M.K.H., AMAKASU, Y., SHIMBARA, S., NAKATANI, Y., ATSUMI, G.-I. & KUDO, I. (1997). Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteblastic cells. J. Biol. Chem., 272, 1989119897.
  • MURRAY, M.D. & BRATER, D.C. (1993). Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu. Rev. Pharmacol. Toxicol., 33, 435465.
  • OTTERNESS, I.G. & MOORE, P.F. (1988). Carrageenan foot edema test. In: Sabato, G.D. (ed.) Methods in Enzymology. Academic Press: San Diego, California pp. 320–327.
  • PENNING, T.D., TALLEY, J.J., BERTENSHAW, S.R., CARTER, J.S., COLLINS, P.W., DOCTER, S., GRANETO, M.J., LEE, L.F., MALECHA, J.W., MIYASHIRO, J.M., ROGERS, R.S., ROGIER, D.J., YU, S.S., ANDERSON, G.D., BURTON, E.G., COGBURN, J.N., GREGORY, S.A., KOBOLDT, C.M., PERKINS, W.E., SEIBERT, K., VEENHUIZEN, A.W., ZHANG, Y.Y. & ISAKSON, P.C. (1997). Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J. Med. Chem., 40, 13471365.
  • PORTANOVA, J.P., ZHANG, Y., ANDERSON, G.D., HAUSER, S.D., MASFERRER, J.L., SEIBERT, K., GREGORY, S.A. & ISAKSON, P.C. (1996). Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med., 184, 883891.
  • RANDALL, L.O. & SELITTO, J.J. (1957). A method for measurement of analgesic activity on inflamed tissue. Arch. Intl. Pharmacodyn, 111, 409419.
  • RIENDEAU, D., PERCIVAL, M.D., BOYCE, S., BRIDEAU, C., CHARLSTON, S., CROMLISH, W., ETHIER, D., EVANS, J., FALGUEYRET, J.P., FORD-HUTCHINSON, A.W., GORDON, R., GREIG, G., GRESSER, M., GUAY, J., KARGMAN, S., LEGER, S., MANCINI, J.A., O'NEILL, G., OUELLET, M., RODGER, I.W., THERIEN, M., WANG, Z., WEBB, J.K., WONG, E. & CHAN, C.C. (1997). Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br. J. Pharmacol., 121, 105117.
  • SEIBERT, K., ZHANG, Y., LEAHY, K., HAUSER, S., MASFERRER, J. & ISAKSON, P. (1997). Distribution of COX-1 and COX-2 in normal and inflamed tissues. Adv. Exp. Med. Biol., 400A, 167170.
  • SEIBERT, K., ZHANG, Y., LEAHY, K., HAUSER, S., MASFERRER, J., PERKINS, W., LEE, L. & ISAKSON, P. (1994). Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA., 91, 1201312017.
  • SMITH, C.J., ZHANG, Y., KOBOLDT, C.M., MUHAMMAD, J., ZWEIFEL, B.S., SHAFFER, A., TALLEY, J.J., MASFERRER, J.L., SEIBERT, K. & ISAKSON, P.C. (1998). Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. USA., 95, 1331313318.
  • SMITH, W.L., MARNETT, L.J. & DEWITT, D.L. (1991). Prostaglandin and thromboxane biosynthesis. Pharmacol. Ther., 49, 153179.
  • SUDA, M., TANAKA, K., YASODA, A., NATSUI, K., SAKUMA, Y., TANAKA, I., USHIKUBI, F., NARUMIYA, S. & NAKAO, K. (1998). Prostaglandin E2 (PGE2) autoamplifies its production through EP1 subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells. Calcif Tissue Int., 62, 327331.
  • TJANDRAWINATA, R.R., DAHIYA, R. & HUGHES-FULFORD, M. (1997). Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Brit. J. Cancer, 75, 11111118.
  • VANE, J.R. & BOTTING, R.M. (1995). New insights into the mode of action of anti-inflammatory drugs. Inflamm. Res., 44, 110.
  • VINEGAR, R., TRUAX, J.F., SELPH, J.L., JOHNSTON, P.R., VENABLE, A.L. & MCKENZIE, K.K. (1987). Pathway to carrageenan-induced inflammation in the hind limb of the rat. Federation Proc., 46, 118126.
  • WALLACE, J.L., REUTER, B., CICALA, C., MCKNIGHT, W., GRISHAM, M.B. & CIRINO, G. (1994). Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology, 107, 173179.
  • ZHANG, Y., SHAFFER, A., PORTANOVA, J., SEIBERT, K. & ISAKSON, P.C. (1997). Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. J. Pharmacol. Exp. Ther., 283, 10691075.